(Press-News.org) A University of Rochester team found a way to make chemotherapy more effective, by stopping a cellular quality-control mechanism, according to a study published today in Nature Communications.
The mechanism is known as NMD (nonsense-mediated mRNA decay), and scientists found that exposing breast cancer cells to a molecule that inhibits NMD prior to treatment with doxorubicin, a drug used to treat leukemia, breast, bone, lung and other cancers, hastens cell death.
The research team, led by Lynne E. Maquat, Ph.D., director of the Center for RNA Biology at the University of Rochester, acknowledges that the work is in the early stages and a long way from being applied in humans. But, they believe their data provide insights that could lead to new treatment strategies for cancer patients in the future.
"The work from Lynne Maquat's lab is critical because it demonstrates the role for NMD in cancer cell survival and shows us how the NDM pathway might be connected to chemotherapy response," said Hartmut "Hucky" Land, Ph.D., director of research at the Wilmot Cancer Institute.
Maximilian Popp, study author and a post-doctoral fellow in Maquat's laboratory, describes NMD as the body's way of proof reading messenger RNA or mRNA, which takes genetic instructions from DNA and uses it to create proteins that carry out our body's functions. NMD flags and derails the production of unwanted proteins that can disrupt normal processes and initiate disease, like an inspector flags and removes faulty products from an assembly line.
In the last several years, Maquat's team and others have discovered that NMD is a more dynamic pathway than they thought; it also helps our cells adjust to changes in their environment and more rapidly respond to certain stimuli.
In the new study, Popp exposed breast cancer cells to doxorubicin alone and measured their viability following treatment. Next, he simultaneously treated cells with doxorubicin and a compound that inhibits NMD. Finally, he treated cells with the compound that inhibits NMD, removed the compound after several hours, and then treated cells with doxorubicin.
The third treatment regimen - NMD-inhibiting compound followed by doxorubicin - was the most effective: cells were two-and-a-half times more likely to die compared to doxorubicin alone. Why this strategy works is not entirely clear, but Maquat and Popp speculate that blocking NMD primes cells for apoptosis (cell death) by boosting the activity of genes that respond to the cellular stress caused by chemotherapy. They note that blocking NMD alone isn't enough to kill breast cancer cells; they need the second stimulus - the doxorubicin - to tip the scale towards apoptosis.
"The idea of combining a drug that inhibits NMD with chemotherapy that is already used to treat a wide range of cancers has the potential to impact patient care," said Popp, a Howard Hughes Medical Institute fellow supported by the Damon Runyon Cancer Research Foundation. "We don't completely understand the detailed mechanisms by which NMD operates, so there is still a lot of work to do, but this study gives us a path forward."
"This research highlights the importance of basic research and its relevance to human disease and therapies," said Maquat, the J. Lowell Orbison Endowed Chair and Professor in the Department of Biochemistry and Biophysics at the University of Rochester School of Medicine and Dentistry. Her lab has spent more than 30 years working to understand the molecular mechanisms of NMD and in 2011 she was elected to the National Academy of Sciences for her research in the field. She is also a recipient of the 2015 Gairdner International Award, Canada's major international science prize for medical researchers whose work contributes significantly to improving the quality of human life.
INFORMATION:
The work was supported by the National Institute for General Medical Sciences at the National Institutes of Health (grant number GM59614 to Maquat) and an Edelman-Gardner seed grant from UR Medicine's Wilmot Cancer Institute.
LAS VEGAS - Orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania have developed two new prediction tools aimed at identifying total hip and knee replacement patients who are at-risk of developing serious complications after surgery. The first tool identifies patients who have risk factors that should disqualify them from undergoing same-day (outpatient) or short-stay (overnight) total hip and knee replacement procedures, opting instead for traditional recovery pathways in the hospital. The second tool identifies which patients should ...
LAS VEGAS - A team of orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania has found that modern technology for healing distal femur fractures is as safe and effective as its more established alternative, without a potential shortfall of the older approach. The team found that when done correctly, there are no significant differences between the two approaches - "locked plating" and "non-locked plating" - in terms of healing rates, need for corrective surgery, or hardware failure. The findings are being presented on Thursday, March ...
The number of total hip replacements (THRs) nearly doubled among middle-aged patients between 2002-2011, primarily due to the expansion of the middle-aged population in the U.S., according to a new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Continued growth in utilization of hip replacement surgery in patients age 45 to 64, an increase in revision surgeries for this population as they age, and a nearly 30 percent decline in the number of surgeons who perform THR, could have significant implications for future ...
A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that black and Hispanic patients were 62 and 50 percent, respectively, more likely to be readmitted to the hospital within 30 days after total joint replacement (TJR) surgery compared to white patients. In addition, Medicaid patients were 40 percent more likely to be readmitted to the hospital than patients with private insurance.
Disparities in the provision of health care services have long been documented, including that black patients utilize hip and ...
While women may have their first total joint replacement (TJR) at an older age, they are less likely to have complications related to their surgery or require revision surgery, according to a new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The findings contradict the theory that TJR is underutilized in female patients because they have worse outcomes then men.
Total hip (THR) and total knee replacement (TKR) are common surgical treatments for end-stage arthritis, which causes ongoing pain, limited function and ...
An injection of a patient's bone marrow stem cells during rotator cuff surgery significantly improved healing and tendon durability, according to a study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Each year in the U.S., more than 2 million people have rotator cuff surgery to re-attach their shoulder tendon to the head of the humerus (upper arm bone). Rotator cuff tears can occur during a fall or when lifting an extremely heavy object; however, most tears are the result of aging and overuse.
The French study, of ...
Nasal drops of harmless bacteria can inhibit a related bug that sometimes causes meningococcal disease, according to new findings published online in Clinical Infectious Diseases. The study--conducted among college students, a group at higher risk for this often serious illness--suggests a new approach that could help suppress outbreaks of the disease, if supported by future research.
Meningococcal disease is caused by Neisseria meningitidis, which can infect the lining of the brain and the spinal cord, causing meningitis. Strains of the bacteria can also cause serious ...
A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting vaccine confidence and hesitation since the new millennium.
The State of Vaccine Confidence Report from researchers at the London School of Hygiene & Tropical Medicine (published 26 March) analyses some of the vaccine confidence issues that have occurred over the past decade with a range of vaccines, reports on strategies that have had positive impacts on engaging populations and building trust and confidence, ...
New research from The University of Manchester out today (26 March) concludes that there is limited evidence to show that xylitol is effective in preventing dental cavities in children and adults.
Xylitol is a natural sweetener that is widely promoted globally, and can be found in wide range of everyday products including sugar-free chewing gum, toothpaste, gels, lozenges and sweets.
Xylitol is a popular sugar substitute in sweets and it is already known to cause less damage to teeth than sugar. It has also been suggested that the addition of xylitol to products may ...
ROCHESTER, Minn. -- As employees and employers face higher health care costs, work site wellness are becoming increasingly more important to help control the costs of health care and encourage healthy lifestyle behaviors among the workforce, a Mayo Clinic study says.
Research published this month in the Journal of Occupational and Environmental Medicine shows that members of Mayo Clinic's employee wellness center, the Dan Abraham Healthy Living Center (DAHLC), who regularly participated in wellness activities, experienced significant weight loss and health care costs ...
